Search

everythinglearnresearchcommunity

for

Search:↓

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

BroadAMP-GPT effectively creates antimicrobial peptides to fight drug-resistant bacteria.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

A new compound effectively inhibits human 5α-reductase 1.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Upadacitinib effectively treats psoriasis and lichen planus together.

Adiantum capillus extract reduces pain and swelling in animals.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Pacing tawar leaves may help treat itching, insect bites, and promote hair growth.

All stray cats in the area have ectoparasite infestations.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.